Ann R. Pokalsky, Partner

Several patents Ms. Pokalsky has prosecuted to issuance have been litigated in the district courts and ultimately upheld by the U.S. Court of Appeals for the Federal Circuit as valid, enforceable, and infringed.

Ms. Pokalsky has been intimately involved with the following types of IP subject matter:

• Medical treatment methods, immunotherapies, gene and enzyme-replacement therapies
• High throughput screening methodologies
• Enzyme variants, peptides and peptide analogs, fusion proteins
• Monoclonal antibodies and receptor antagonists
• Vaccines
• Nucleoside and nucleotide derivatives, oligonucleotides
• Diagnostic assays
• Vector and expression constructs, chimeric genes, gene silencing constructs, siRNAs
• Biologics and biologic formulations
• Small molecule drugs, drug combinations, formulations and pharmaceutical compositions
• Transformed and transgenic cells, expression systems, engineered tissue
• Transgenic plants and plant parts
• Medical devices
• Chemical and biochemical compounds and processes

Ms. Pokalsky advises and counsels clients on a wide variety of IP law topics, including trade secret law. She conducts due diligence reviews, advises on global patent filings and prosecution strategies, reviews and manages patent portfolios, and performs patent landscape analyses. In addition, she prepares inventorship, patentability, invalidity, freedom to operate, and non-infringement opinions, as well as licensing, sponsored research, non-disclosure and material transfer agreements.Prior to starting her law career, Ms. Pokalsky was a research associate at a biotechnology company, where she co-authored several papers published in peer-reviewed journals and was a named co-inventor on a U.S. patent directed to use of an EF1α gene promoter.